News NextCell Pharma AB

Equities

NXTCL

SE0009723125

Delayed Nasdaq Stockholm Other stock markets 04:06:24 10/06/2024 pm IST			5-day change	1st Jan Change
1.43 ^SEK	-15.88%		+0.70%	-45.63%

28/05	NextCell Pharma AB Announces Single Treatment with ProTrans Demonstrates Long-Term Therapeutic Effect over 5 Years	CI
27/05	Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cellaviva becomes an independent company under NextCell Pharma	05/06	AQ
NextCell procures top guarantee in ongoing rights issue	05/06	AQ
The subscription period in NextCell's rights issue commences today	31/05	AQ
NextCell publishes prospectus in connection with the rights issue of units of approximately SEK 40.1 million	30/05	AQ
Single treatment with ProTrans demonstrates long-term therapeutic effect over 5 years	28/05	AQ
NextCell Pharma AB Announces Single Treatment with ProTrans Demonstrates Long-Term Therapeutic Effect over 5 Years	28/05	CI
Bulletin from the Extraordinary General Meeting of NextCell Pharma AB (publ)	27/05	AQ
Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board	27/05	CI
NextCell publishes its Interim Report 2 2023/2024	25/04	AQ
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	25/04	CI
Notice of Extraordinary General Meeting in NextCell Pharma AB (publ)	24/04	AQ
The Board of Directors of NextCell resolves on a rights issue of units of approximately SEK 40.1 million, subject to approval by an Extraordinary General Meeting	24/04	AQ
NextCell's daughter company Cellaviva granted permission to handle amniotic tissue	22/04	AQ
NextCell Pharma AB Announces Swedish Health and Social Care Inspectorate Grants Their Cellaviva Tissue Establishment Permission to Handle Amniotic Tissue	22/04	CI
NextCell Pharma Chairman to Step Down in May	19/04	MT
Anders Essen-Möller resigns as Chairman of the Board of Directors due to health reasons	19/04	AQ
Anders Essen-Möller Resigns as Chairman of NextCell Pharma AB	19/04	CI
The Swedish Medical Products Agency approves subgroup analysis in NextCell's ProTrans-Young study	27/03	AQ
The Swedish Medical Products Agency Approves Subgroup Analysis in NextCell Pharma AB's ProTrans-Young study	27/03	CI
NextCell establishes QVance to meet the Nordic's need for quality analytics	14/03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NextCell Pharma AB

Equities

NXTCL

SE0009723125

Summary

Filters